Burundi

in page functions
[French]
Burundi
Total population (2017) 11,936,457
Birth cohort (2017) 507,688
Surviving Infants (surviving to 1 year per year, 2017) 471,382
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 54/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 82/1000
World Bank Index, IDA (2015) 3.07
Gross Nation Income (per capita US$, 2015) 260
Co-financing group (2017) Initial self-financing
No. of districts/territories (2015) 45

Contact Gavi

For more info, contact Gavi country representative officer or email here

Gavi support for Burundi

Type of support

Approvals

2001-2021 (US$)
(23 Mar 2017)

Commitments

2001-2021 (US$)
(23 Mar 2017)

Disbursements

2000-2017 (US$)
(23 Mar 2017)

% Disbursed

(23 Mar 2017)
2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Total $122,179,655 $122,204,655 $123,606,776
Cash Support (CASHSUPP) $173,214 $198,214 $173,214 100%
Civil Society Organisation support (CSO) $461,520 $461,520 $494,529 107%
Health system strengthening (HSS 1) $8,252,000 $8,252,000 $8,252,000 100%
Health system strengthening (HSS 2) $16,382,663 $16,382,663 $15,522,663 95%
HepB mono (NVS) $460,000 $460,000 $460,000 100%
HPV Demo (NVS) $239,043 $239,043 $126,410 53%
Immunisation services support (ISS) $3,669,980 $3,669,980 $3,669,980 100%
Injection Safety Devices (NVS) $112,000 $112,000 $143,756 128%
Injection safety support (INS) $390,294 $390,294 $390,294 100%
IPV (NVS) $784,718 $784,718 $779,873 99%
Measles (NVS) $411,003 $411,003 $431,185 105%
Measles-Rubella (NVS) $2,902,000 $2,902,000 $3,027,951 104%
MR - Operational costs (OPC) $2,646,573 $2,646,573 $2,646,573 100%
Penta (NVS) $35,011,911 $35,011,911 $34,330,671 98%
Pneumo (NVS) $36,827,686 $36,827,686 $40,651,815 110%
Product Switch Grant (PSG) $117,500 $117,500
Rotavirus (NVS) $6,977,766 $6,977,766 $6,146,076 88%
Tetra DTP-Hib (NVS) $4,727,594 $4,727,594 $4,727,594 100%
Vaccine Introduction Grant (VIG) $1,632,191 $1,632,191 $1,632,191 100%

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Burundi DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2015)

Grade of confidence


N/A
DTP3 - Official country estimates (2015) 94%
M:F sex ratio at birth (2017) 1.03
Household survey: DTP3 coverage for male (2009) 95.50%
Household survey: DTP3 coverage for female (2009) 95.20%
Household survey: Last DTP3 survey (2009) 95%
% districts achieving > 80% DTP3 coverage (2015) 89%
% districts achieving < 50% DTP3 coverage (2015) 0%
MCV WHO/UNICEF estimates (2015) 93%

Breakdown of support

Non-vaccine support Vaccine support
27% 73%
$32,781,442 $90,825,330

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Burundi

22 February 2016

Gavi item

Meningitis A nearly eliminated in Africa through vaccination

Joint press release first published by WHO and PATH, joint founders of the Meningitis Vaccine Project.

22 April 2014

World Immunisation Week 2014

Message by Dr Seth Berkley for the World Immunisation Week

04 February 2014

HPV vaccine with GAVI support

206,000 more girls to benefit from HPV vaccine with GAVI Alliance support

10 countries approved in latest round of HPV vaccine demonstration programmes.

close icon

modal window here